↓ Skip to main content

Cocaine and HIV-1 Interplay: Molecular Mechanisms of Action and Addiction

Overview of attention for article published in Journal of Neuroimmune Pharmacology, July 2011
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
47 Mendeley
Title
Cocaine and HIV-1 Interplay: Molecular Mechanisms of Action and Addiction
Published in
Journal of Neuroimmune Pharmacology, July 2011
DOI 10.1007/s11481-011-9297-0
Pubmed ID
Authors

Shilpa Buch, Honghong Yao, Minglei Guo, Tomohisa Mori, Tsung-Ping Su, John Wang

Abstract

Human immunodeficiency virus (HIV) infection is now being driven by drug-abusing populations. Epidemiological studies on drug abusers with AIDS link abuse of cocaine, even more than other drugs, to increased incidence of HIV seroprevalence and progression to AIDS. Both cell culture and animal studies demonstrate that cocaine can both potentiate HIV replication and can potentiate HIV proteins to cause enhanced glial cell activation, neurotoxicity, and breakdown of the blood-brain barrier. Based on the ability of both HIV proteins and cocaine to modulate NMDA receptor on neurons, NMDA receptors have been suggested as a common link underlying the crosstalk between drug addiction and HIV infection. While the role of dopamine system as a major target of cocaine cannot be overlooked, recent studies on the role of sigma receptors in mediating the effects of cocaine in both cell and organ systems warrants a deeper understanding of their functional role in the field. In this review, recent findings on the interplay of HIV infection and cocaine abuse and their possible implications in mode of action and/or addiction will be discussed.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 6%
Unknown 44 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 15 32%
Researcher 5 11%
Student > Doctoral Student 4 9%
Other 4 9%
Student > Master 4 9%
Other 7 15%
Unknown 8 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 12 26%
Neuroscience 4 9%
Medicine and Dentistry 4 9%
Biochemistry, Genetics and Molecular Biology 3 6%
Immunology and Microbiology 3 6%
Other 8 17%
Unknown 13 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2020.
All research outputs
#15,270,937
of 24,217,893 outputs
Outputs from Journal of Neuroimmune Pharmacology
#351
of 583 outputs
Outputs of similar age
#83,315
of 120,046 outputs
Outputs of similar age from Journal of Neuroimmune Pharmacology
#11
of 16 outputs
Altmetric has tracked 24,217,893 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 583 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 120,046 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.